An Evaluation of the WHO QUAlityRights Program
Launched by GCS-CCOMS · Mar 7, 2025
Trial Information
Current as of May 09, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the World Health Organization's QualityRights (QR) program, which aims to enhance mental health care by ensuring that facilities respect the rights and needs of their patients. The study will explore whether this program makes people feel more satisfied with their mental health care. Researchers will compare the experiences of patients receiving care under the QR program with those receiving standard care practices.
To participate in this study, you need to be an adult aged 18 or older and have been hospitalized in a psychiatric unit for at least three days. You also need to agree to join the study. Mental health professionals who have been working in the field for at least three months can also participate. However, individuals who cannot participate due to physical or mental health issues, those under legal protection, or those who do not speak or understand French will not be included. If you join, you can expect to share your experiences with mental health care, which will help researchers understand how to improve services for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (18 years or older)
- • Persons having formulated a non-opposition to participate in the study
- • Population a (users): Service users of the psychiatric sectors involved in the study hospitalized full-time since at least 3 days in an inpatient unit.
- • Population b (professionals): Mental health professionals working in the sector since at least 3 months at the time of study participation
- Exclusion Criteria:
- • Persons physically or psychologically unable to participate at the time of the study
- • Persons subject to a safeguard of justice measure
- • Persons who do not speak or understand the French language
About Gcs Ccoms
GCS-CCOMS is a leading clinical trial sponsor dedicated to advancing innovative therapies through rigorous research and development. With a strong commitment to enhancing patient outcomes, the organization specializes in the design, implementation, and management of clinical trials across various therapeutic areas. GCS-CCOMS collaborates with academic institutions, healthcare providers, and pharmaceutical companies to ensure the highest standards of scientific integrity and regulatory compliance. Through a patient-centered approach and a focus on ethical practices, GCS-CCOMS strives to contribute to the advancement of medical knowledge and improve the quality of care available to patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Armentières, , France
Armentières, , France
Erstein, , France
Laxou, , France
Montéléger, , France
Nanterre, , France
Nice, , France
Plaisir, , France
Plaisir, , France
Pont Du Casse, , France
Patients applied
Trial Officials
Déborah Sebbane, MD, PhD
Study Chair
GCS-CCOMS & ECEVE 1123 INSERM
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported